Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis

Schizophrenia Bulletin

Volumn 35, Issue 2, 2009, Pages 437-442

  Fernandez Egea, Emilio ^a,b   Bernardo, Miguel ^c,d   Heaphy, Christopher M ^e   Griffith, Jeffrey K ^e   Parellada, Eduard ^c,d   Esmatjes, Enric ^c,d   Conget, Ignacio ^c,d   Nguyen, Linh ^f   George, Varghese ^f   Stöppler, Hubert ^g   Kirkpatrick, Brian ^f  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CAMBRIDGESHIRE AND PETERBOROUGH NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF BARCELONA   (Spain)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^e UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^f MEDICAL COLLEGE OF GEORGIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetes; Psychosis; Pulse pressure; Schizophrenia; Telomere

Indexed keywords

GLUCOSE; HYDROCORTISONE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BODY MASS; BRIEF PSYCHOTIC DISORDER; CHROMOSOME SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DELUSIONAL DISORDER; ETHNICITY; FEMALE; HUMAN; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PSYCHOSIS; PULSE PRESSURE; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SEX DIFFERENCE; SMOKING HABIT; SOCIAL STATUS; TELOMERE;

ADOLESCENT; ADULT; AGING; ANTIPSYCHOTIC AGENTS; BLOOD PRESSURE; DIABETES MELLITUS; DIASTOLE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYDROCORTISONE; LEUKOCYTES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; TELOMERE;

EID: 65349098187     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbn169     Document Type: Article

References (40)

1. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64:1123-1131.
2. Consensus development conference on antipsychotic drugs and obesity and diabetes. J. Clin Psychiatry. 2004;65: 267-272.
3. McGrath J, El-Saadi O, Grim V, et al. Minor physical anomalies and quantitative measures of the head and face in patients with psychosis. Arch Gen Psychiatry. 2002;59:458-464.
4. Spelman LM, Walsh PI, Sharifi N, Collins P, Thakore JH. Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia. Diabet Med. 2007;24:481-485.
5. Ryan MC, Collins P, Thakore JH. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry. 2003;160:284-289.
6. Kooy F. Hyperglycemia in mental state. Brain. 1919;42: 214-290.
7. Lorenz WF. Sugar tolerance in dementia praecox and other mental disorders. Arch Neurol Psychiatry. 1922;8:184-186.
8. Bowman CM. Biochemical studies in ten cases of dementia praecox. Boston Med Surg J. 1922;9:187-358.
9. Kasanin J. The blood sugar curve in mental disease, II: the schizophrenic (dementia praecox) group. Arch Neurol Psychiatry. 1926;16:414-419.
10. Freeman H. Resistance to insulin in mentally disturbed soldiers. Arch Neurol Psychiatry. 1946;56:74-78.
11. Freeman H, Rodnick EH, Shakow D, Lebeaux T. The carbo-hydrate tolerance of mentally disturbed soldiers. Psychosom Med. 1944;6:311-317.
12. Braceland FJ, Meduna FJ, Vaichulis JA. Delayed action of insulin in schizophrenia. Am J Psychiatry. 1945;102:108-110.
13. Freitag MH, Peila R, Masaki K, et al. Midlife pulse pressure and incidence of dementia: the Honolulu-Asia Aging Study. Stroke. 2006;37:33-37.
14. Glynn RJ, Chae CU, Guralnik JM, Taylor JO, Hennekens CH. Pulse pressure and mortality in older people. Arch Intern Med. 2000;160:2765-2772.
15. O'Rourke MF, Mancia G. Arterial stiffness.J. Hypertens. 1999;17:1-4.
16. Sengstock DM, Vaitkevicius PV, Supiano MA. Arterial stiffness is related to insulin resistance in nondiabetic hypertensive older adults. J. Clin Endocrinol Metab. 2005;90:2823-2827.
17. Gardner JP, Li S, Srinivasan SR, et al. Rise in insulin resistance is associated with escalated telomere attrition. Circulation. 2005;111:2171-2177.
18. Adaikalakoteswari A, Balasubramanyam M, Ravikumar R, Deepa R, Mohan V. Association of telomere shortening with impaired glucose tolerance and diabetic macroangiop-athy. Atherosclerosis. 2007;185:83-89.
19. Fitzpatrick AL, Kronmal RA, Gardner JP, et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol. 2007;165:14-21.
20. Martin-Ruiz C, Dickinson HO, Keys B, Rowan E, Kenny RA, von ZT. Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann Neurol. 2006;60: 174-180.
21. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003;361: 393-395.
22. Balasubramanyam M, Adaikalakoteswari A, Monickaraj SF, Mohan V. Telomere shortening & metabolic/vascular diseases. Indian J Med Res. 2007;125:441-450.
23. Sampson MJ, Winterbone MS, Hughes JC, Dozio N, Hughes DA. Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care. 2006;29:283-289.
24. Obana N, Takagi S, Kinouchi Y, et al. Telomere shortening of peripheral blood mononuclear cells in coronary disease patients with metabolic disorders. Intern Med. 2003;42:150-153.
25. Addington J, Saeedi H, Addington D. The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome. Schizophr Res. 2005;78:35-43.
26. Fernandez-Egea E, Bernardo M, Donner T, et al. The metabolic profile of antipsychotic-naïve patients with nonaffective psychosis. Br J Psychiatry. 2009; (In press).
27. Fernandez-Egea E, Bernardo M, Parellada E, et al. Glucose abnormalities in the siblings of people with schizophrenia. Schizophr Res. 2008;103:110-113.
28. Fernandez-Egea E, Miller B, Bernardo M, Donner T, Kirkpatrick B. Parental history of Type 2 diabetes in patients with nonaffective psychosis. Schizophr Res. 2008;98:302-306.
29. Fordyce CA, Heaphy CM, Bisoffi M, et al. Telomere content correlates with stage and prognosis in breast cancer. Breast Cancer Res Treat. 2006;99:193-202.
30. Kao HT, Cawthon RM, Delisi LE, et al. Rapid telomere erosion in schizophrenia. Mol Psychiatry. 2008;13:118-119.
31. Yu WY, Chang HW, Lin CH, Cho CL. Short telomeres in patients with chronic schizophrenia who show a poor response to treatment. J Psychiatry Neurosci. 2008;33:244-247.
32. Chen JH, Hales CN, Ozanne SE. DNA damage, cellular senescence and organismal ageing: causal or correlative? Nucleic Acids Res. 2007;35:7417-7428.
33. Jeanclos E, Krolewski A, Skurnick J, et al. Shortened telomere length in white blood cells of patients with IDDM. Diabetes. 1998;47:482-486.
34. Adaikalakoteswari A, Balasubramanyam M, Mohan V. Telomere shortening occurs in Asian Indian Type 2 diabetic patients. Diabet Med. 2005;22:1151-1156.
35. Yao JK, Leonard S, Reddy R. Altered glutathione redox state in schizophrenia. Dis Markers. 2006;22:83-93.
36. Benetos A, Okuda K, Lajemi M, et al. Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension. 2001;37:381-385.
37. Aeschbacher BC, Hutter D, Fuhrer J, Weidmann P, Delacretaz E, Allemann Y. Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens. 2001;14:106-113.
38. Ronnback M, Fagerudd J, Forsblom C, Pettersson-Fernholm K, Reunanen A, Groop PH. Altered age-related blood pressure pattern in type 1 diabetes. Circulation. 2004;110:1076-1082.
39. Kirkpatrick B, Messias E, Harvey PD, Fernandez-Egea E, Bowie CR. Is schizophrenia a syndrome of accelerated aging? Schizophr Bull. 2008;34:1024-1032.
40. Koenig JI, Kirkpatrick B, Lee P. Glucocorticoid hormones and early brain development in schizophrenia. Neuropsycho-pharmacology. 2002;27:309-318.